Elanco

The company traces its roots back to 1953 when Eli Lilly introduced their first antibiotic aimed at veterinary usage, with the new plant and animal sciences research being combined into Lilly's Agro-industrial division led by George Barnes.{{Citation needed|date=November 2024}} In the 1960s, the Agro-Industrial division was reorganised launching Elanco Products, short for the parent company name, Eli Lilly and Company.{{Citation needed|date=November 2024}}

In the 1980s, research moved away from plant sciences and focused on animal health and food quality. In the 1990s, another reorganisation led to the company being renamed Elanco Animal Health, focusing solely on animal health.{{Citation needed|date=November 2024}}

In 2007, the business acquired Ivy Animal Health and launched its companion animal business. In 2008, Elanco partnered with Heifer International. In 2009, the business launched its data analytics business, Elanco Knowledge Solutions.{{Citation needed|date=November 2024}}

In 2010, the business acquired the European rights to a portfolio of Pfizer Animal Health treatments and an Irish manufacturing site.{{Citation needed|date=November 2024}} In 2011, Elanco expanded its footprint in Europe, acquiring Janssen Animal Health. In 2012, the business acquired ChemGen Corp.{{Cite web |url=https://www.elanco.com/news/press-releases/elanco-acquires-chemgen-leading-enzyme-company |title=Elanco Animal Health Announces Lilly's Agreement to Acquire ChemGen Corp. |website=www.elanco.com |date=24 January 2012 |url-status=dead |archive-url=https://web.archive.org/web/20200717134417/https://www.elanco.com/news/press-releases/elanco-acquires-chemgen-leading-enzyme-company |archive-date=17 July 2020 |access-date=17 July 2020 }} In 2014, the business acquired Lohmann SE and Lohmann Animal Health for an undisclosed sum and Novartis Animal Health for $5.4 billion. In 2016, Elanco expanded its US-based business, acquiring vaccines from Boehringer Ingelheim Vetmedica for $885 million.{{Citation needed|date=November 2024}}

In 2013, Elanco made a $100M investment in China Animal Healthcare.{{Cite web|url=https://www.feedstuffs.com/story-elanco-invests-in-china-animal-healthcare-52-97134|title=Elanco invests in China Animal Healthcare|website=www.feedstuffs.com|date=12 April 2013 }}

In 2018, Lilly announced plans to separate its Elanco Animal Health unit from the rest of the business via an initial public offering on the New York Stock Exchange, with the stock-ticker ELAN. In 2019, the divestiture was completed and Elanco launched on the New York Stock Exchange. In the same year, the US FDA approved rabacfosadine, a first-in-class treatment for canine lymphoma. The business continued to expand is US-business, acquiring Aratana Therapeutics, and its first-in-class treatment for canine osteoarthritis. Elanco also announced it would acquire the developer of vaccines for bacterial disease prevention in food-animals, Prevtec Microbia, Inc. In the same year, the business announced it would acquire Bayer's animal health business for $7.6 billion.{{Cite news|url=https://uk.reuters.com/article/us-bayer-m-a-elanco-animal-competition-b-idUKKCN24F2NJ|archive-url=https://web.archive.org/web/20200714231906/https://uk.reuters.com/article/us-bayer-m-a-elanco-animal-competition-b-idUKKCN24F2NJ|url-status=dead|archive-date=14 July 2020|title=Elanco to divest brands, forgo Canadian rights for Bayer's unit deal|newspaper=Reuters|date=14 July 2020|via=uk.reuters.com}}{{Cite news|url=https://uk.reuters.com/article/us-bayer-animal-health-m-a-elanco-animal-idUKKCN24G2AD|archive-url=https://web.archive.org/web/20200717140054/https://uk.reuters.com/article/us-bayer-animal-health-m-a-elanco-animal-idUKKCN24G2AD|url-status=dead|archive-date=17 July 2020|title=Elanco Animal Health wins approval to buy Bayer unit|newspaper=Reuters|date=15 July 2020|via=uk.reuters.com}}

On December 3, 2020, Elanco announced plans to build a new global headquarters in Indianapolis at the site of the former GM stamping plant, which is located across the White River from the downtown area. The business plans to break ground on the new headquarters in the first half of 2021.{{Cite web|last=Burris|first=Alexandria|title=Former GM stamping plant will be home to Elanco Animal Health headquarters|url=https://www.indystar.com/story/money/2020/12/04/gm-stamping-plant-site-become-home-elanco-animal-health-hq/3821748001/|access-date=2020-12-05|website=The Indianapolis Star|language=en-US}}{{Needs update|date=September 2022|reason=Date passed}}

In August 2021, Elanco announced it had closed its acquisition of Kindred Biosciences.{{Cite web |date=August 30, 2021 |title=Elanco Closes Acquisition of Kindred Biosciences |url=https://www.biospace.com/article/releases/elanco-closes-acquisition-of-kindred-biosciences/?s=79 |website=biospace.com}}

Elanco's flea and tick collar, branded "Seresto," which was developed by Bayer Animal Health and acquired by Elanco in 2020, has been linked to more than 98,000 incidents of poisoning by pesticide, including more than 2,000 pet deaths, according to a 2022 report by a subcommittee of the House Committee on Oversight and Reform. The collars are not registered for sale in Canada.{{cite web | title=Lawmakers say this flea collar should be recalled after 2,500 pet deaths | website=FOX13 News | date=June 16, 2022 | url=https://www.q13fox.com/news/seresto-flea-tick-collar-pet-deaths-recall-epa | access-date=June 16, 2022}}{{cite web | last=Novak | first=Matt | title=Seresto Flea Collars Might Be Banned After Lawmakers Grill CEO | website=Gizmodo | date=June 16, 2022 | url=https://gizmodo.com/seresto-flea-collars-might-be-banned-after-lawmakers-gr-1849069454 | access-date=June 16, 2022}}

On July 13, 2023, following a multi-year review, the EPA announced that they were unable to determine whether Seresto was the cause of reported animal deaths. The EPA limited the collar's registration to five years instead of the normal fifteen years registration, as other pesticides normally receive. Elanco and the EPA also agreed to develop a program designed to enhance data collection for adverse event reports and continued annual enhanced reporting of Seresto adverse event data.{{cite news |last= Hettinger |first= Johnathan |date= July 14, 2023 |title= EPA rules popular Seresto flea collar stays on the market, adds more reporting requirements |url= https://www.usatoday.com/story/news/investigations/2023/07/14/epa-leaves-seresto-flea-collar-on-market-after-studying-pet-effects/70414721007/ |publisher= USA Today |access-date= August 8, 2023 }}

{{hidden begin|border=1px #aaa solid|title=Elanco Acquisitions|ta1=center}}

{{Tree list}}

• Elanco Products Company (Established 1954 as a division of Eli Lilly and Company)
• DowElanco (Established 1989 as joint venture with Dow Chemical, Sold stake 1999 to Dow)
• Ivy Animal Health{{cite web | url=http://lilly.mediaroom.com/index.php?s=9042&item=12328 | title=Eli Lilly and Company Announces Acquisition of Ivy Animal Health | publisher=PRNewswire | date=25 May 2007}} (Acq 2007)
• Pfizer Animal Health{{cite web | url=http://lilly.mediaroom.com/index.php?s=9042&item=6125 | title=Lilly to Acquire European Rights to Pfizer Animal Health Assets | publisher=PRNewswire | date=8 March 2010}} (Acq 2010)
• Janssen Pharmaceutica Animal Health{{cite web | url=http://lilly.mediaroom.com/index.php?s=9042&item=30256 | title=Lilly Makes an Irrevocable Offer to Acquire Janssen Animal Health | publisher=PRNewswire | date=14 March 2011}} (Acq 2011)
• ChemGen Corp{{cite web | url=http://lilly.mediaroom.com/index.php?s=9042&item=111145 | title=Elanco Animal Health Announces Lilly's Agreement to Acquire ChemGen Corp. | publisher=PRNewswire | date=24 January 2012}} (Acq 2012)
• Lohmann SE{{cite web| url=http://lilly.mediaroom.com/index.php?s=9042&item=137283| title=Elanco Announces Agreement to Acquire Lohmann Animal Health| publisher=PRNewswire| date=24 February 2014| access-date=17 July 2020| archive-date=28 June 2017| archive-url=https://web.archive.org/web/20170628120456/http://lilly.mediaroom.com/index.php?s=9042| url-status=dead}} (Acq 2014)
• Lohmann Animal Health (Acq 2014)
• Novartis Animal Health (Acq 2014)
• Bayer Animal Health (Acq 2019)
• Kindred Biosciences (Acq 2021)

{{Tree list/end}}

{{hidden end}}

{{Reflist}}

• {{official|https://www.elanco.com}}

{{Finance links

| name = Elanco Animal Health Incorporated

| symbol = ELAN

| reuters = ELAN.N

| bloomberg = ELAN:US

| sec_cik = ELAN

| yahoo = ELAN

| google = ELAN:NYSE

}}

{{authority control}}

Category:Veterinary medicine companies

Category:Pharmaceutical companies of the United States

Category:Health care companies based in Indiana

Category:Companies based in Indianapolis

Category:Companies listed on the New York Stock Exchange

Category:2018 initial public offerings

Category:Eli Lilly and Company

Category:Veterinary medicine in the United States

Category:Corporate spin-offs